HRSA Lifts Major Barrier to Using 340B Drugs at Hospital Offsite Locations

In Federal, RegulatoryJune 4, 202040 Views

Happy Thursday from Publisher and CEO Ted Slafsky: Our sponsors are 340B’s industry leaders and we are proud to showcase their innovative solutions and guidance to help you implement and comply with this complex program. In today’s issue, you will learn more from LicenseTrak founder Tony Zappa about his company’s solutions for keeping track of your compliance and licensure requirements. Click on the button below or reach me at ted.slafsky@340BReport.com to learn more about the many benefits of becoming a sponsor.

Become a Sponsor

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

HRSA Lifts Major Barrier to Using 340B Drugs at Hospital Offsite Locations

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga

HRSA Lifts Major Barrier to Using 340B Drugs at Hospital Offsite Locations

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Tom Mirga

Site Footer